AtriCure, Inc. (ATRC)
NASDAQ: ATRC · Real-Time Price · USD
29.39
-0.63 (-2.10%)
At close: Mar 9, 2026, 4:00 PM EDT
29.39
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:10 PM EDT
AtriCure Revenue
In the year 2025, AtriCure had annual revenue of $534.53M with 14.88% growth. AtriCure had revenue of $140.50M in the quarter ending December 31, 2025, with 13.05% growth.
Revenue (ttm)
$534.53M
Revenue Growth
+14.88%
P/S Ratio
2.74
Revenue / Employee
$395,947
Employees
1,350
Market Cap
1.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 534.53M | 69.22M | 14.88% |
| Dec 31, 2024 | 465.31M | 66.06M | 16.55% |
| Dec 31, 2023 | 399.25M | 68.87M | 20.84% |
| Dec 31, 2022 | 330.38M | 56.05M | 20.43% |
| Dec 31, 2021 | 274.33M | 67.80M | 32.83% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DENTSPLY SIRONA | 3.68B |
| ICU Medical | 2.23B |
| Warby Parker | 871.91M |
| Azenta | 595.03M |
| LeMaitre Vascular | 249.60M |
| STAAR Surgical Company | 239.44M |
| BioLife Solutions | 96.21M |
| Kestra Medical Technologies | 74.26M |
ATRC News
- 13 days ago - AtriCure to Participate in the Citizens Life Sciences Conference - Business Wire
- 19 days ago - AtriCure, Inc. (ATRC) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 20 days ago - AtriCure Reports Fourth Quarter 2025 and Full Year 2025 Financial Results - Business Wire
- 5 weeks ago - AtriCure to Announce Fourth Quarter and Full Year 2025 Financial Results - Business Wire
- 7 weeks ago - AtriCure, Inc. (ATRC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2025, Provides Financial Outlook for 2026 - Business Wire
- 2 months ago - AtriCure to Participate in the J.P. Morgan 44th Annual Healthcare Conference - Business Wire
- 3 months ago - AtriCure Announces the First Patients Treated with Novel Dual Energy Platform - Business Wire